HIV, HCV & Leprosy co-infection

Area of Science:

• Infectious Diseases
• Dermatology
• Virology

Background:

• Hansen's disease (leprosy) elimination in India presents a challenge for managing co-infections.
• Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) co-infections are significant global health concerns.
• Intravenous drug use is a known risk factor for HIV and HCV transmission.

Observation:

• A young intravenous drug abuser presented with lepromatous Hansen's disease in type 2 reaction.
• Testing revealed incidental co-infection with HIV and HCV.
• This represents a unique triple co-infection scenario.

Findings:

• The patient exhibited lepromatous Hansen's disease with a type 2 reaction.
• Simultaneous diagnosis of HIV and HCV infections was made.
• This is the first reported case of leprosy co-infected with both HIV and HCV.

Implications:

• This case highlights the potential for HIV and HCV co-infection to influence Hansen's disease presentation.
• Such triple infections may pose challenges for diagnosis and treatment strategies.
• Increased surveillance for co-infections in individuals with Hansen's disease is warranted, particularly in at-risk populations.